Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    "Pulmonic stenosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Pulmonic stenosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Pulmonary Arteriopathy-Diagnostics and Therapy
Condition: Pulmonary Stenosis
Intervention:
2 Terminated Mild Valvar Pulmonary Stenosis
Condition: Congenital Disorders
Intervention:
3 Recruiting Right and Left Ventricle Remodeling Predictors After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot
Condition: Tetralogy of Fallot With Pulmonary Stenosis
Intervention: Other: MRI
4 Recruiting Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
Conditions: Peripheral Pulmonary Stenosis;   In-stent Stenosis
Intervention: Drug: Sirolimus
5 Active, not recruiting Follow Up on Freestyle Valves in Children
Conditions: Right Ventricle;   Pulmonary Valve Stenosis;   Pulmonary Valve Atresia
Intervention: Procedure: Echocardiogram
6 Active, not recruiting Pulmonic Valve REplacement Multi-discIpline EMEA Registry
Conditions: Pulmonary Regurgitation;   Pulmonary Insufficiency;   Pulmonary Stenosis
Intervention: Device: Transcatheter Pulmonic Valve Replacement (TPVR) (Edwards SAPIEN™ THV)
7 Active, not recruiting
Has Results
Pulmonary Artery Repair With Covered Stents
Conditions: Pulmonary Stenosis;   Pulmonary Regurgitation;   Tetralogy of Fallot
Intervention: Device: Repair of RV-PA Conduit Disruption
8 Active, not recruiting
Has Results
COMPASSION: COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Conditions: Pulmonary Valve Insufficiency;   Pulmonary Regurgitation;   Dysfunctional RVOT Conduit;   Pulmonary Obstruction;   Pulmonary Stenosis
Intervention: Device: SAPIEN Transcatheter Valve Implantation
9 Active, not recruiting A Feasibility Study to Evaluate the Safety and Short-term Effectiveness of Transcatheter Pulmonary Valve (TPV)
Conditions: Congenital Heart Defects;   Cardiovascular Abnormalities;   Pulmonary Valve Insufficiency;   Pulmonary Valve Stenosis
Intervention: Device: Transcatheter Pulmonary Valve (TPV)
10 Completed
Has Results
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Conditions: Pulmonary Valve Stenosis;   Pulmonary Valve Insufficiency;   Aortic Valve Stenosis;   Aortic Valve Insufficiency
Intervention: Procedure: Echocardiogram
11 Completed Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
Conditions: Hypoparathyroidism;   Tetralogy of Fallot;   Pulmonary Valve Stenosis;   Conotruncal Cardiac Defects;   Heart Defects, Congenital;   Pulmonary Atresia
Interventions: Drug: calcium gluconate;   Drug: sodium citrate
12 Completed Reproduction and Survival After Cardiac Defect Repair
Conditions: Cardiovascular Diseases;   Heart Diseases;   Defect, Congenital Heart;   Aortic Valve Stenosis;   Transposition of Great Vessels;   Ductus Arteriosus, Patent;   Heart Septal Defects, Atrial;   Heart Septal Defects, Ventricular;   Down Syndrome;   Tetralogy of Fallot;   Pulmonic Stenosis;   Coarctation of Aorta
Intervention:
13 Completed Retrospective Pulmonary Valve Replacement Imaging
Condition: Congenital Heart Disease
Intervention:
14 Not yet recruiting Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes
Conditions: Noonan Syndrome;   LEOPARD Syndrome
Intervention:
15 Recruiting Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Conditions: Complex Congenital Heart Defect;   Dysfunctional RVOT Conduits
Intervention: Device: SAPIEN 3 THV

Study has passed its completion date and status has not been verified in more than two years.